Abstract
The Orsiro sirolimus-eluting stent is designed with ultrathin struts and biodegradable polymer, conferring potential favourable clinical outcomes. A recent meta-analysis comparing the Orsiro stent to contemporary drug-eluting stents showed similar outcomes, with a trend toward lesser target lesion failure and myocardial infarction (MI).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
